I-Sep

About:

Auto-transfusion specialist through innovative technology for the separation of blood components.

Top Investors: GO CAPITAL

Description:

i-SEP is a French Medtech specializing in auto-transfusion and the Patient Blood Management. i-SEP has developed a completely innovative technology for the separation of blood components. Our ambition is to become the first French start-up to market a self-transfusion system capable of recovering both red blood cells and platelets during hemorrhagic surgical procedures. i-SEP works in close collaboration with the surgical teams of reference with missions to improve the patient benefit, simplify the work of practitioners and help reduce hospital costs.

Total Funding Amount:

2.03M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Nantes, Pays de la Loire, France

Founded Date:

2015-01-01

Founders:

Bertrand Chastenet, Francis Gadrat, Sylvain Picot

Number of Employees:

11-50

Last Funding Date:

2017-04-05

IPO Status:

Private

Industries: